Total Payments
$3,011
2024 Payments
$149.21
Companies
34
Transactions
141
Medicare Patients
2,216
Medicare Billing
$268,856
Payment Breakdown by Category
Food & Beverage$2,921 (97.0%)
Education$89.98 (3.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,921 | 139 | 97.0% |
| Education | $89.98 | 2 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $425.42 | 24 | $0 (2024) |
| Allergan, Inc. | $213.25 | 7 | $0 (2021) |
| Genentech USA, Inc. | $205.68 | 8 | $0 (2020) |
| Lundbeck LLC | $194.61 | 9 | $0 (2024) |
| Biogen, Inc. | $178.56 | 7 | $0 (2020) |
| Amgen Inc. | $151.67 | 6 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $139.53 | 6 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $135.57 | 7 | $0 (2020) |
| UCB, Inc. | $133.00 | 6 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $116.89 | 5 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $149.21 | 6 | Eisai Inc. ($48.15) |
| 2023 | $464.07 | 23 | AbbVie Inc. ($243.57) |
| 2022 | $334.01 | 17 | ABBVIE INC. ($121.28) |
| 2021 | $90.03 | 4 | AbbVie Inc. ($28.86) |
| 2020 | $689.17 | 30 | Allergan, Inc. ($145.24) |
| 2019 | $1,285 | 61 | Genentech USA, Inc. ($188.52) |
All Payment Transactions
141 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/23/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Neurology | ||||||
| 05/16/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $35.32 | General |
| 05/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: PSYCHIATRY | ||||||
| 05/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $31.71 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Neurology | ||||||
| 02/08/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.57 | General |
| Category: NEUROLOGY | ||||||
| 11/27/2023 | AbbVie Inc. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2023 | AbbVie Inc. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $33.44 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.13 | General |
| Category: PSYCHIATRY | ||||||
| 10/26/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: Neurology | ||||||
| 08/10/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $22.00 | General |
| Category: NEUROLOGY | ||||||
| 07/13/2023 | Jazz Pharmaceuticals Inc. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: NEUROLOGY | ||||||
| 06/16/2023 | Life Molecular Imaging Ltd | NEURACEQ (Drug) | Food and Beverage | Cash or cash equivalent | $23.74 | General |
| Category: Diagnostic Tracer | ||||||
| 06/14/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/04/2023 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Neuroscience | ||||||
| 04/14/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.75 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/15/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $33.61 | General |
| Category: NEUROLOGY | ||||||
| 02/02/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.04 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 571 | 759 | $198,446 | $69,045 |
| 2022 | 10 | 587 | 739 | $197,862 | $72,125 |
| 2021 | 11 | 573 | 757 | $198,465 | $76,824 |
| 2020 | 9 | 485 | 564 | $146,807 | $50,862 |
Total Patients
2,216
Total Services
2,819
Medicare Billing
$268,856
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 210 | 309 | $71,070 | $25,189 | 35.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 126 | 213 | $41,109 | $16,017 | 39.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 70 | 70 | $25,620 | $8,126 | 31.7% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 49 | 49 | $19,894 | $6,367 | 32.0% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 26 | 26 | $12,766 | $3,698 | 29.0% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 30 | 30 | $9,240 | $3,000 | 32.5% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 15 | 15 | $8,640 | $2,733 | 31.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 17 | $5,457 | $2,155 | 39.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 30 | $4,650 | $1,760 | 37.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 188 | 267 | $61,410 | $24,406 | 39.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 117 | 117 | $42,822 | $13,316 | 31.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 98 | 167 | $32,231 | $13,216 | 41.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 46 | 46 | $14,766 | $5,892 | 39.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 26 | 26 | $12,766 | $4,154 | 32.5% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 28 | 28 | $11,368 | $3,655 | 32.1% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 28 | 29 | $8,932 | $2,659 | 29.8% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 12 | 12 | $6,912 | $2,252 | 32.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 26 | $4,030 | $1,754 | 43.5% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 21 | 21 | $2,625 | $820.08 | 31.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 154 | 244 | $56,120 | $23,307 | 41.5% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 130 | 219 | $42,267 | $17,847 | 42.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 93 | 93 | $34,038 | $11,546 | 33.9% |
| 95909 | Nerve transmission studies, 5-6 studies | Office | 2021 | 51 | 51 | $15,708 | $5,773 | 36.8% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2021 | 33 | 33 | $16,203 | $5,576 | 34.4% |
| 95912 | Nerve transmission studies, 11-12 studies | Office | 2021 | 22 | 22 | $12,672 | $4,517 | 35.6% |
About Dr. Carl Waldman, MD
Dr. Carl Waldman, MD is a Neurology healthcare provider based in West Chester, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1750371274.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carl Waldman, MD has received a total of $3,011 in payments from pharmaceutical and medical device companies, with $149.21 received in 2024. These payments were reported across 141 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($2,921).
As a Medicare-enrolled provider, Waldman has provided services to 2,216 Medicare beneficiaries, totaling 2,819 services with total Medicare billing of $268,856. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location West Chester, PA
- Active Since 10/26/2005
- Last Updated 03/25/2019
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1750371274
Products in Payments
- UBRELVY (Drug) $344.18
- BOTOX (Biological) $225.71
- OCREVUS (Biological) $205.68
- Aimovig (Biological) $151.67
- TROKENDI XR (Drug) $116.89
- Briviact (Drug) $114.86
- SOLIRIS (Drug) $114.84
- APTIOM (Drug) $113.12
- VYEPTI (Biological) $104.84
- EMGALITY (Drug) $103.46
- Epidiolex (Drug) $85.66
- TYSABRI (Biological) $85.64
- MAYZENT (Drug) $71.95
- TECFIDERA (Drug) $70.54
- QULIPTA (Drug) $68.78
- AJOVY (Drug) $61.49
- Trudhesa (Drug) $57.46
- NORTHERA (Drug) $53.95
- AUBAGIO (Drug) $49.81
- Leqembi (Drug) $48.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in West Chester
Dr. Mark Callow, Md, MD
Neurology — Payments: $62,306
Neurology $62,306
Joyce Liporace, Md, MD
Neurology — Payments: $34,530
Neurology $34,530
Etsegenet Tizazu, Md, MD
Neurology — Payments: $15,354
Neurology $15,354
Dr. Fred Weinblatt, Md, MD
Neurology — Payments: $14,662
Neurology $14,662
Dr. Mark Macnealy, Do, Jd, DO, JD
Neurology — Payments: $7,323
Neurology $7,323
Dr. Mohamad Rahwan, M.d, M.D
Neurology — Payments: $5,191
Neurology $5,191